Michael A. Zasloff, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 30,770 shares at $14.20 ($437K) on 2015-12-17, disclosed to the SEC on 2015-12-17.
Scheduled sale ($437k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.19 | 16,538 | $235K | 53.7% |
| 2 | $14.20 | 14,232 | $202K | 46.3% |
| Total | $14.19 avg | 30,770 | $437K | 100% |
| Filing → |
| AMPH | SELL | 2023-05-16 | $316K | — | Filing → |
| AMPH | SELL | 2022-05-17 | $733K | — | Filing → |
| AMPH | SELL | 2022-03-17 | $337K | — | Filing → |